CanBas Co (TSE:4575) EV-to-FCF: (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4575 CanBas Co Ltd TSE:4575
31 GF Score
Price 円796.00
View Full Analysis

What is CanBas Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CanBas Co's Enterprise Value is 円13,918.33 Mil. CanBas Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was 円0.00 Mil. Therefore, CanBas Co's EV-to-FCF for today is .

The historical rank and industry rank for CanBas Co's EV-to-FCF or its related term are showing as below:

TSE:4575' s EV-to-FCF Range Over the Past 10 Years
Min: -17.07   Med: 0   Max: 0
Current: -17.07

TSE:4575's EV-to-FCF is ranked worse than
100% of 336 companies
in the Biotechnology industry
Industry Median: 15.32 vs TSE:4575: -17.07

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-15), CanBas Co's stock price is 円796.00. CanBas Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円-50.040. Therefore, CanBas Co's PE Ratio (TTM) for today is At Loss.


CanBas Co  (TSE:4575) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

CanBas Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=796.00/-50.040
=At Loss

CanBas Co's share price for today is 円796.00.
CanBas Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-50.040.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


CanBas Co EV-to-FCF Related Terms


CanBas Co EV-to-FCF Historical Data

* Premium members only.

The historical data trend for CanBas Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanBas Co EV-to-FCF Chart

CanBas Co Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.50 -9.89 -13.26 -6.17 -26.85

CanBas Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -26.85 0.00 0.00 0.00

TSE:4575 vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, CanBas Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanBas Co EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CanBas Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where CanBas Co's EV-to-FCF falls into.


TSE:4575
31GF Score
CanBas Co Ltd TSE:4575
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CanBas Co EV-to-FCF Calculation

CanBas Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=13918.331/0
=

CanBas Co's current Enterprise Value is 円13,918.33 Mil.
CanBas Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanBas Co Business Description

Address 2-2-1 Otemachi, Numazu, Shizuoka, JPN, 410-0891
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.
31GF Score

Get the complete analysis for TSE:4575

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円796.00
Price